|
Market Closed -
NYSE
21:00:00 12/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.780 USD | 0.00% |
|
+2.58% | +54.44% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 11 | +295.68% | 2 | |||||
| 1,330.14 | +12.47% | 29 | ||||||
| 279.82 | +6.1% | 22 | ||||||
| 282.61 | +0.53% | 28 | ||||||
| 158.64 | +9.07% | 25 | ||||||
| 377.24 | +4.79% | 19 | ||||||
| 150.18 | +4.48% | 22 | ||||||
| 208.96 | +31.52% | 23 | ||||||
| 393.91 | -5.67% | 29 | ||||||
| 159.62 | +6.11% | 26 | ||||||
| 306.51 | +19.55% | 23 | ||||||
| 29.26 | +3.03% | 26 | ||||||
| 571.43 | +12.71% | 28 | ||||||
| 65.83 | +14.33% | 24 | ||||||
| 980.67 | +2.61% | 12 | ||||||
| 93.56 | +30.67% | 24 | ||||||
| 21.73 | +22.69% | 21 | ||||||
| 122.67 | -42.61% | 18 | ||||||
| 859.69 | +12.7% | 26 | ||||||
| 154.21 | +11.23% | 14 | ||||||
| Average | 327.88 | +22.60% | 22 | ||||||
| Weighted average by Cap. | 499.65 | +8.45% | 25 |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
